221 related articles for article (PubMed ID: 34912824)
21. Artemether Alleviates Diabetic Kidney Disease by Modulating Amino Acid Metabolism.
Rong G; Weng W; Huang J; Chen Y; Yu X; Yuan R; Gu X; Wu X; Cai Y; Han P; Shao M; Sun H; Ge N
Biomed Res Int; 2022; 2022():7339611. PubMed ID: 35601149
[TBL] [Abstract][Full Text] [Related]
22. Elevated plasma myoglobin level is closely associated with type 2 diabetic kidney disease.
Yang L; Shen Y; Li W; Zha B; Xu W; Ding H
J Diabetes; 2024 Mar; 16(3):e13508. PubMed ID: 38036859
[TBL] [Abstract][Full Text] [Related]
23. Serum and Urinary Progranulin in Diabetic Kidney Disease.
Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
[TBL] [Abstract][Full Text] [Related]
24. Serum metabolite profiling of familial adenomatous polyposis using ultra performance liquid chromatography and tandem mass spectrometry.
Sun L; Kang Q; Pan Y; Li N; Wang X; He Y; Wang H; Yu D; Xie H; Yang L; Lu Y; Jin P; Sheng J
Cancer Biol Ther; 2019; 20(7):1017-1028. PubMed ID: 30983515
[TBL] [Abstract][Full Text] [Related]
25. Atherogenic Index of Plasma as an Early Marker of Chronic Kidney Disease and Liver Injury in Type 2 Diabetes.
Li H; Miao X; Zhong J; Zhu Z
Clin Med Insights Endocrinol Diabetes; 2024; 17():11795514241259741. PubMed ID: 38859965
[TBL] [Abstract][Full Text] [Related]
26. Serum branched chain amino acids: an effective indicator of diabetic kidney disease.
Liu M; Yang Y; Liu Y; Peng X; Hou Y; Zhang X; Sun H; Shan C
Front Endocrinol (Lausanne); 2023; 14():1269633. PubMed ID: 38089615
[TBL] [Abstract][Full Text] [Related]
27. Integration of metabolomics and peptidomics reveals distinct molecular landscape of human diabetic kidney disease.
Jiang X; Liu X; Qu X; Zhu P; Wo F; Xu X; Jin J; He Q; Wu J
Theranostics; 2023; 13(10):3188-3203. PubMed ID: 37351171
[TBL] [Abstract][Full Text] [Related]
28. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
Zhu C; Liang QL; Hu P; Wang YM; Luo GA
Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
[TBL] [Abstract][Full Text] [Related]
29. Metabolomics reveal mitochondrial and fatty acid metabolism disorders that contribute to the development of DKD in T2DM patients.
Li L; Wang C; Yang H; Liu S; Lu Y; Fu P; Liu J
Mol Biosyst; 2017 Oct; 13(11):2392-2400. PubMed ID: 28956034
[TBL] [Abstract][Full Text] [Related]
30. Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study.
Laiakis EC; Morris GA; Fornace AJ; Howie SR
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844590
[TBL] [Abstract][Full Text] [Related]
31. Serum metabolic profiling analysis of gout patients based on UPLC-Q-TOF/MS.
Zhong Z; Huang Y; Huang Q; Zheng S; Huang Z; Deng W; Li T
Clin Chim Acta; 2021 Apr; 515():52-60. PubMed ID: 33388309
[TBL] [Abstract][Full Text] [Related]
32. Identification of Potential Serum Metabolic Biomarkers of Diabetic Kidney Disease: A Widely Targeted Metabolomics Study.
Zhang H; Zuo JJ; Dong SS; Lan Y; Wu CW; Mao GY; Zheng C
J Diabetes Res; 2020; 2020():3049098. PubMed ID: 32190695
[TBL] [Abstract][Full Text] [Related]
33. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
[TBL] [Abstract][Full Text] [Related]
34. Lipidomics study of plasma phospholipid metabolism in early type 2 diabetes rats with ancient prescription Huang-Qi-San intervention by UPLC/Q-TOF-MS and correlation coefficient.
Wu X; Zhu JC; Zhang Y; Li WM; Rong XL; Feng YF
Chem Biol Interact; 2016 Aug; 256():71-84. PubMed ID: 27369808
[TBL] [Abstract][Full Text] [Related]
35. Metabolic Homeostasis of Amino Acids and Diabetic Kidney Disease.
Liu L; Xu J; Zhang Z; Ren D; Wu Y; Wang D; Zhang Y; Zhao S; Chen Q; Wang T
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615841
[TBL] [Abstract][Full Text] [Related]
36. Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients.
Issar T; Arnold R; Kwai NCG; Walker S; Yan A; Borire AA; Poynten AM; Pussell BA; Endre ZH; Kiernan MC; Krishnan AV
Clin Neurophysiol; 2019 Nov; 130(11):2088-2095. PubMed ID: 31541986
[TBL] [Abstract][Full Text] [Related]
37. Metabolomics for Age Discrimination of Ginseng Using a Multiplex Approach to HR-MAS NMR Spectroscopy, UPLC-QTOF/MS, and GC × GC-TOF/MS.
Yoon D; Choi BR; Ma S; Lee JW; Jo IH; Lee YS; Kim GS; Kim S; Lee DY
Molecules; 2019 Jun; 24(13):. PubMed ID: 31252608
[TBL] [Abstract][Full Text] [Related]
38. Mass spectrometry with derivatization method for concurrent measurement of amino acids and acylcarnitines in plasma of diabetic type 2 patients with diabetic nephropathy.
Esmati P; Najjar N; Emamgholipour S; Hosseinkhani S; Arjmand B; Soleimani A; Kakaii A; Razi F
J Diabetes Metab Disord; 2021 Jun; 20(1):591-599. PubMed ID: 34222079
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum level of pancreatic stone protein/regenerating protein (PSP/reg) is observed in diabetic kidney disease.
Li L; Jia D; Graf R; Yang J
Oncotarget; 2017 Jun; 8(24):38145-38151. PubMed ID: 28418911
[TBL] [Abstract][Full Text] [Related]
40.
Lin HT; Cheng ML; Lo CJ; Lin G; Lin SF; Yeh JT; Ho HY; Lin JR; Liu FC
J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31248127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
